We are live on ! Find out more
AVDL

Avadel Pharmaceuticals
AVDL

Delisted

AVDL was delisted on the 11th of February, 2026.

Back to rankings

207 hedge funds and large institutions have $1.6B invested in Avadel Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 69 funds opening new positions, 44 increasing their positions, 72 reducing their positions, and 49 closing their positions.

New
Increased
Maintained
Reduced
Closed

121% more call options, than puts

Call options by funds: $100M | Put options by funds: $45.3M

41% more first-time investments, than exits

New positions opened: 69 | Existing positions closed: 49

31% more capital invested

Capital invested by funds: $1.22B → $1.6B (+$376M)

10% more funds holding

Funds holding: 188 → 207 (+19)

0% more funds holding in top 10

Funds holding in top 10: 8 → 8 (0)

6.83% less ownership

Funds ownership: 82.36% → 75.53% (-6.8%)

39% less repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 72

Holders
207
Holders Change
+19
Holders Change %
+10.11%
% of All Funds
2.51%
Holding in Top 10
8
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
69
Increased
44
Reduced
72
Closed
49
Calls
$100M
Puts
$45.3M
Net Calls
+$55M
Net Calls Change
+$42.8M

Top Buyers

Rank Fund Capital Flow
1
WAM
Weiss Asset Management
Massachusetts
+$87.7M
2
TAL
TIG Advisors LLC
New York
+$74.9M
3
Tudor Investment Corp
Tudor Investment Corp
Connecticut
+$57.1M
4
Fidelity International
Fidelity International
Bermuda
+$54.8M
5
HCM
Highbridge Capital Management
New York
+$39.8M

Top Sellers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$109M
2
BIP
Brandes Investment Partners
California
-$101M
3
TSC
Two Seas Capital
New York
-$82M
4
PCH
Polar Capital Holdings
United Kingdom
-$61.1M
5
Morgan Stanley
Morgan Stanley
New York
-$33.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
YCM
51
Yakira Capital Management
Connecticut
$5.71M +$5.15M +265,195 New
Pictet Asset Management
52
Pictet Asset Management
Switzerland
$5.71M +$4.94M +254,551 +2,442%
AAA
53
Affinity Asset Advisors
New York
$5.39M +$4.85M +250,000 New
IAM
54
Iridian Asset Management
Connecticut
$5.32M -$48.5K -2,500 -1%
VI
55
Versor Investments
New York
$5.26M +$4.74M +244,019 New
Bank of New York Mellon
56
Bank of New York Mellon
New York
$5.19M -$140K -7,232 -3%
NPT
57
National Philanthropic Trust
Pennsylvania
$4.73M – – –
BIP
58
Brandes Investment Partners
California
$4.71M -$101M -5,226,378 -96%
MML Investors Services
59
MML Investors Services
Massachusetts
$4.69M -$191K -9,820 -4%
CCM
60
Cinctive Capital Management
New York
$4.31M +$3.88M +200,000 New
Swiss National Bank
61
Swiss National Bank
Switzerland
$3.72M +$85.4K +4,400 +3%
NICM
62
Neo Ivy Capital Management
New York
$3.43M +$3.09M +159,165 New
VCM
63
Voleon Capital Management
California
$3.31M +$2.98M +153,607 New
ACM
64
ADAR1 Capital Management
Texas
$3.24M +$2.92M +150,532 New
MTCM
65
Mint Tower Capital Management
Netherlands
$3.23M +$2.91M +150,000 New
Barclays
66
Barclays
United Kingdom
$3.21M -$29.4K -1,515 -1%
Man Group
67
Man Group
United Kingdom
$3.02M +$2.05M +105,684 +308%
Wells Fargo
68
Wells Fargo
California
$3.02M +$731K +37,654 +37%
JF
69
Jump Financial
Illinois
$2.95M -$8.02M -412,859 -75%
D.E. Shaw & Co
70
D.E. Shaw & Co
New York
$2.85M -$4.6M -237,170 -64%
JP Morgan Chase
71
JP Morgan Chase
New York
$2.64M -$8.6M -442,995 -78%
YIH
72
Y-Intercept (HK)
Hong Kong
$2.6M -$203K -10,457 -8%
HF
73
HRT Financial
New York
$2.53M +$2.28M +117,259 New
Legal & General Group
74
Legal & General Group
United Kingdom
$2.47M -$218K -11,248 -9%
HWAM
75
Hennion & Walsh Asset Management
New Jersey
$2.42M +$519K +26,731 +31%
1 2
3
4 5

AVDL Hedge Fund Activity: Q4 2025 in Review

207 of the 8,252 institutional investors tracked by Wall St. Rank reported a position in Avadel Pharmaceuticals (AVDL) for Q4 2025, worth a combined $1.6B — up 31% from $1.22B a quarter earlier.

Buyers outnumbered sellers: 69 funds opened new AVDL positions and 49 closed out — a net gain of 20 holders — while 44 added to existing stakes and 72 trimmed.

The largest buyer was Weiss Asset Management, opening a new position worth an estimated $87.7M. The largest seller was Janus Henderson Group, cutting an estimated $109M.

  • 207 institutional investors held Avadel Pharmaceuticals (AVDL) as of Q4 2025, up from 188 in Q3 2025.
  • Funds reported $1.6B of Avadel Pharmaceuticals stock for Q4 2025, up 31% quarter-over-quarter.
  • 69 funds opened new Avadel Pharmaceuticals positions in Q4 2025 and 49 closed out, a net change of +20 holders.
  • The largest Avadel Pharmaceuticals buyer in Q4 2025 was Weiss Asset Management, an estimated $87.7M added.
  • The largest Avadel Pharmaceuticals seller in Q4 2025 was Janus Henderson Group, an estimated $109M sold.

Based on aggregated 13F filings for Q4 2025.